RxAnte, a leading provider of analytics, software, and services for pharmacy care management, announced a strategic growth investment from Primus Capital. This partnership is intended to accelerate RxAnte’s expansion of its value-based pharmacy solutions and enhance clinical service offerings for health plans and their members who require advanced drug therapy management.
Health Technology Insights: Allink Biotherapeutics Secures $47Million Series A Extension
RxAnte has pioneered the use of healthcare data and analytics to identify risks from unsafe medication use, improve prescribing and adherence, and measure outcomes for vulnerable populations. In 2026, the company expects to manage care for over 34 million lives through partnerships with both regional and national health plans. The investment from Primus Capital comes as Mosaic Pharmacy Service, RxAnte’s technology-driven pharmacy care subsidiary, experiences rapid growth. Mosaic provides personalized, data-focused pharmacy care for medically complex and socially vulnerable patients. Peer-reviewed studies conducted in collaboration with UPMC Health Plan show that Mosaic improves member health, reduces hospitalizations, lowers medical costs, and enhances quality scores. UPMC has partnered with RxAnte since 2016 and is recognized globally as a leading healthcare provider and insurer.
Health Technology Insights: Cosette Pharma Launches First Generic CIPRO HC with CGT Exclusivity
Josh Benner, Co-Founder and CEO of RxAnte, said the partnership with Primus Capital represents a significant milestone for the company. He explained that as drug costs rise and medication use continues to be closely monitored for quality, pharmacy care must be more personalized and coordinated than ever. He highlighted that with guidance and collaboration from UPMC, RxAnte has developed a unique value-based model that supports patients with complex medical and social needs.
Brent Burns, Executive Vice President of UPMC Enterprises, the organization’s innovation, commercialization, and venture capital arm, emphasized that Primus Capital shares RxAnte’s vision of data-driven pharmacy care management as a major opportunity to improve health outcomes while lowering overall healthcare costs. He stated that the new partnership will help bring RxAnte’s solutions to more patients more quickly.
Primus Capital, a private equity firm with extensive experience in high-growth healthcare technology and service companies, identified RxAnte as a market leader in pharmacy care management. Phil Molner, Managing Partner of Primus Capital, expressed excitement about the partnership, praising RxAnte’s data-driven platform for addressing one of healthcare’s most challenging and costly problems. He noted that Primus is committed to supporting RxAnte’s continued innovation and growth as the company reshapes the role of pharmacy in delivering better patient outcomes.
Health Technology Insights: Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
